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The CASPAR (Coronary Artery Spasm in
Patients With Acute Coronary Syndrome) Study
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Matthias Voehringer, MD, Udo Sechtem, MD
Stuttgart, Germany
Objectives This study was conducted to clarify the incidence of coronary spasm in emergency patients with suspected acute
coronary syndrome (ACS) and acute chest pain at rest.
Background Chest pain at rest is a frequent symptom in the emergency room. Acute coronary syndrome is suspected in pa-
tients with elevation of cardiac markers, ischemic electrocardiographic changes, or simply typical clinical symp-
toms of unstable (usually resting) angina. However, of all patients with suspected ACS who undergo coronary
angiography, up to 30% have nonobstructed coronary arteries. We sought to clarify how many of these patients
suffer from coronary spasm as a possible cause of their chest pain.
Methods In a prospective study from June to December 2006, all patients with suspected ACS who underwent coronary
angiography and had no culprit lesion underwent intracoronary provocation with acetylcholine. The ACH testing
was considered positive at a vasoconstriction of 75% relative to the diameter after intracoronary nitroglycerine
when the initially reported symptoms could be reproduced.
Results Of 488 consecutive patients, 138 had no culprit lesion (28%). Twenty-two were found to have another diagnosis. The
ACH testing was performed in 86 of the remaining 116 patients. In 42 patients, coronary spasm was verified (49%).
Conclusions Every fourth patient with ACS had no culprit lesion. Coronary spasm could be documented in nearly 50% of the
patients tested by ACH. Coronary spasm is a frequent cause of ACS and should regularly be considered as a dif-
ferential diagnosis. (J Am Coll Cardiol 2008;52:523–7) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.04.050n
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chest pain at rest is one of the most frequent symptoms of
atients in the emergency room (1). The diagnosis of acute
oronary syndrome (ACS) is suspected in these patients,
specially when typical electrocardiographic (ECG) changes
nd/or elevation of cardiac markers can be detected. How-
ver, of all patients who undergo coronary angiography
ecause of suspected ACS, up to 30% have unobstructed
oronary arteries or at least no culprit lesion that could
xplain the patient’s discomfort (2,3). Potential other causes
or the clinical symptoms encompass a variety of diagnoses.
See page 528
ossible extracardial causes can be pulmonary, gastroesoph-
geal, musculoskeletal, or psychiatric (4). Apart from coro-
rom the Department of Cardiology and Pulmology, Robert-Bosch-Krankenhaus,
tuttgart, Germany.(
Manuscript received November 20, 2007; revised manuscript received April 24,
008, accepted April 29, 2008.ary embolism or thrombosis (5), diseases such as myocar-
itis (6) or tako-tsubo-cardiomyopathy (7) have also been
escribed in these patients.
Coronary spasm is another well-defined mechanism for
CS causing ischemia at rest (8). However, only 2 studies
xamined the frequency of coronary spasm in patients with
CS and unobstructed coronary arteries. Whereas a high
revalence (74%) of ergonovine-provoked coronary spasm
as found in a Taiwanese population (8), a similar study in
aucasian patients documented coronary spasm only in 16%
9). Therefore, we sought to prospectively investigate the
requency of coronary spasm in patients with ACS including
ll presentations (ST-segment elevation myocardial infarc-
ion [STEMI], non–ST-segment elevation myocardial in-
arction [NSTEMI], unstable angina pectoris [UAP]) who
howed no culprit lesion or hemodynamically relevant ste-
osis (50%) at coronary angiography. Intracoronary provo-
ation for coronary spasm was done using acetylcholine
ACH) (10).
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Patient population and ACH
test. In a prospective study from
June to December 2006, 488
consecutive patients who under-
went coronary angiography be-
cause of ACS were registered and
written informed consent for an
additional intracoronary ACH
provocation was obtained. The
study complied with the Decla-
ration of Helsinki. We defined
ACS as acute chest pain (i.e.,
chest pain at rest 20 min
within the last 48 h) together
with ECG changes suggesting
yocardial ischemia and/or elevation of cardiac markers
11). In case of detection of a culprit lesion, percutaneous
oronary intervention was performed or coronary artery
ypass grafting or conservative treatment was recom-
ended. If coronary angiography revealed no culprit lesion,
e conducted an ACH test. Incremental doses of 2, 20, and
00 g ACH were injected into the left coronary artery via
he diagnostic catheter for 3 min each (10,12). If the test in
he left coronary artery was negative, 80 g ACH was
njected into the right coronary artery. When coronary
pasm was demonstrated, 0.2 mg of Perlinganit (glycerol-
rinitrate, Schwarz Pharma, Monheim, Germany) was in-
ected into the responsible vessel.
The ACH test was performed either at primary cathe-
erization or in a second session depending on the patient’s
ondition and the administered medication. It was not
erformed in one of the following conditions: patient
efusal, suspected myocarditis, tako-tsubo-cardiomyopathy,
evere chronic obstructive pulmonary disease, severe renal
nsufficiency, allergy to iodinated contrast media.
Abbreviations
and Acronyms
ACH  acetylcholine
ACS  acute coronary
syndrome
ECG  electrocardiogram
LCA  left coronary artery
NSTEMI  non–ST-segment
elevation myocardial
infarction
STEMI  ST-segment
elevation myocardial
infarction
UAP  unstable angina
pectoris
Patient Main Clinical Characteristics
Table 1 Patient Main Clinical Characteristic
All Patients
n 488
Gender, male 315 (64.5%)
Age, yrs (mean  SD) 66 (12)
Risk factors
Hypertension 310 (70.6%)
Diabetes mellitus 126 (28.8%)
Hypercholesterolemia 262 (59.8%)
Smokers 118 (26.7%)
Obesity 69 (15.8%)
Positive family history of CVD 141 (32.3%)
Cardiac markers and LVEF
LVEF, % (IQR) 61 (47–71)
TnI, g/l, n  0.16 (IQR) 1.70 (0.04–22.01)
CK, U/l, n  180 (IQR) 143 (69–599)
BNP, pg/ml, n  80 (IQR) 193 (67–600)BNP  B-type natriuretic peptide; CK  creatine kinase; CVD  cardiovascula
fraction; NS  not significant; TnI  troponin I.uantitative analysis. All ACH tests were quantitatively
nalyzed with QCA-CMS 7.0 (Medis-Software, Leiden,
he Netherlands). The ACH test was positive when the
isual findings at coronary angiography and the quantitative
nalysis confirmed a vasoconstriction of 75% compared
ith the relaxed state after intracoronary administration of
lyceroltrinitrate together with a reproduction of the pa-
ient’s initial symptoms (10,13,14).
tatistics. Results are expressed as mean  standard devi-
tion. The t test was used to compare continuous variables.
or values without normal distribution, median and inter-
uartile ranges are stated and Mann-Whitney U test was
sed. The chi-square test was used for categorical and
rdinal variables. A two-tailed p value 0.05 was consid-
red significant. Data analysis was done with SPSS 14.0
SPSS Inc., Chicago, Illinois).
esults
aseline characteristics. A total of 488 patients were
ncluded (Table 1). They were divided into 2 groups
epending on the presence or absence of a culprit lesion at
oronary angiography. Patients with culprit lesion were
lder, were more often male, and showed significantly
igher levels of cardiac markers. In addition, these patients
ad a significantly lower left ventricular ejection fraction.
here was a higher prevalence of diabetes mellitus in the
roup with culprit lesion (p  0.002). The distribution of
CS in the 2 groups is shown in Figure 1. In patients with
ulprit lesion, STEMI and NSTEMI were significantly
ore prevalent than in patients without culprit lesion (p 
.001).
atients without culprit lesion. We identified 138 pa-
ients without culprit lesion. In 22 patients, the diagnosis
ould be determined before the ACH test. Nine patients
6.5% of all patients without culprit lesion) had myocarditis
hat was diagnosed by cardiac magnetic resonance imaging
t Lesion Present Culprit Lesion Absent p Value
350 138
(71.1%) 66 (47.8%) 0.0001
(12) 62 (13) 0.0001
(71.9%) 87 (67.4%) NS
(33%) 24 (18.6%) 0.002
(61.2%) 73 (56.6%) NS
(28.7%) 28 (21.9%) NS
(15.5%) 21 (16.4%) NS
(28.1%) 54 (42.2%) 0.001
(44–69) 59 (39–69) 0.001
(0.49–51.76) 0.02 (0.02–0.28) 0.001
(115–714) 83 (56–128) 0.001
(80–1018) 59 (25–178) 0.001s
Culpri
249
67
223
102
189
90
48
87
56
6.41
332
247r diseases; IQR  interquartile range; LVEF  left ventricular ejection
a
h
a
p
w
t
A
p
s
u
l
p
2
A
e
w
p
(
t
A
r
w
t
d
p
3
o
i
E
b
E
t
b
D
A
h
p
r
o
s
t
p
A
7
i
o
c
c
C
A
525JACC Vol. 52, No. 7, 2008 Ong et al.
August 12, 2008:523–7 Coronary Spasm as Frequent Cause of ACSnd later confirmed by endomyocardial biopsy, 7 patients
ad tako-tsubo-cardiomyopathy (5%), 1 patient had an
cute bleeding, and 1 had pulmonary embolism. Four other
atients already had a positive previous ACH test result and
ere hence assumed to have coronary spasm as the cause of
heir recurrent chest pain.
Eighty-six of the remaining 116 patients underwent the
CH test (74%). In 30 patients the ACH test could not be
erformed because of the abovementioned reasons. Coronary
pasm was verified in 42 patients (49% of the patients who
nderwent the test and 30% of all patients without culprit
esion) (Table 2). The remaining 44 patients showed different
atterns of reproduction of symptoms and vasoreaction (Fig.
). Of all 86 patients without culprit lesion who underwent
CH testing, 7 patients showed significant troponin I
Figure 1 Presentation of ACS (n  488)
Distribution of different presentations of ACS according to presence or
absence of culprit lesion. ACS  acute coronary syndrome; NSTEMI  non–ST-
segment elevation myocardial infarction; STEMI  ST-segment elevation myo-
cardial infarction; UAP  unstable angina pectoris.
linical Characteristics of Patients Withoutulprit Lesion Who Had an Acetylchol ne Test
Table 2 Clinical Characteristics of Patients WithoutCulprit Lesion Who Had an Acetylcholine Test
Spasm
Present
Spasm
Absent
p
Value
n 42 44
Gender, male 21 (50%) 25 (56.8%) NS
Age, yrs (median) 60 (12) 61 (11) NS
Risk factors
Hypertension 27 (64.2%) 29 (65.9%) NS
Diabetes mellitus 8 (19%) 7 (15.9%) NS
Hypercholesterolemia 26 (61.9%) 22 (50%) NS
Smokers 10 (23.8%) 8 (18.1%) NS
Obesity 6 (14.2%) 6 (13.6%) NS
Positive family history of CVD 22 (52.3%) 21 (47.7%) NS
Cardiac markers and LVEF
LVEF, % (IQR) 70 (62–79) 71% (62–77) NS
TnI, g/l, n  0.16 (IQR) 0.02 (0.02–0.03) 0.02 (0.02–0.02) NS
CK, U/l, n  180 (IQR) 73.5 (55.5–134.5) 79 (49–120) NS
BNP, pg/ml, n  80 (IQR) 48 (23–68) 60 (22.5–176) NSebbreviations as in Table 1.levation. Coronary spasm was found in 4 (57%) of them,
hich was not statistically different from the 43% (3 of 7)
atients who had coronary spasm without marker elevation
p  0.696). Thus, there was no association between
roponin levels and spasm.
CH test and ECG. Intracoronary admission of ACH
eproduced exactly the same chest pain in 42 of 50 patients
ho had coronary spasm by angiography. The ECG of
hese 42 patients showed ischemic ST-segment changes
uring or after ACH administration (17 ST-segment de-
ression, 3 ST-segment elevation) in 20 patients (48%). In
other patients who had only a 6-lead ECG, spasm was
cclusive, which is highly likely to be associated with
schemia, but there were no visible changes in the 6-lead
CG. In 6 patients the ECG could not be interpreted (5
ecause of left bundle branch block, 1 because of pacemaker
CG). In the remaining 13 patients it was not possible to
ell whether there were signs of ischemia in the ECG
ecause of technical problems or only 6-lead registration.
iscussion
lmost 50% of our patients who underwent the ACH test
ad proof of coronary spasm. If one includes the 4 other
atients who already had a positive previous ACH test
esult, this proportion increases to slightly above 50%. No
ther study in consecutive Caucasian patients has ever
hown a plausible cardiac explanation for the occurrence of
he clinical picture of ACS in such a high number of
atients with normal coronary arteries.
ll patients. Of patients with ACS included in our study,
2% had a culprit lesion at coronary angiography. Patients
n this group were older and presented significantly more
ften with STEMI and NSTEMI than the group without a
ulprit lesion. Thus, it is not surprising that patients with a
ulprit lesion had a significantly lower left ventricular
Figure 2 ACH Test (n  86)
Distribution of different vasoreactions to acetylcholine
(ACH) according to reproduction of the patient’s initial symptoms.jection fraction, higher levels of cardiac markers, and a
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Coronary Spasm as Frequent Cause of ACS August 12, 2008:523–7igher prevalence of diabetes mellitus. Patients with culprit
esions were more often male, confirming a previous obser-
ation of a higher prevalence of women in the group of
atients with ACS but without significant coronary artery
isease (15).
atients without culprit lesion. In contrast to our results,
a Costa et al. (9) found that only 16% of French patients
ith myocardial infarction and normal coronary arteries had
rgonovine-induced coronary spasm. A potential explana-
ion for this discrepancy is the different inclusion criteria.
heir patients had to have chest pain, ECG changes, and
ncreased plasma enzyme activity, whereas our patients had
o have chest pain at rest 20 min and only one of either
schemic ECG changes or elevation of cardiac markers.
owever, after matching our patients with the inclusion
riteria of Da Costa et al. (9), we still found 50% of our
atients with coronary spasm, which is 3 times more
requent than in their study.
Could the different method of application used to pro-
oke coronary spasm explain the different proportions of
asospasm in the study by Da Costa et al. (9) and our study?
pplication of ergonovine in their patients was done intra-
enously, whereas we used intracoronary application of
CH. This methodical difference could have contributed to
he lower percentage of positive tests in the study by Da
osta et al. (9). Goto et al. (16) showed that in patients with
hest pain who underwent intravenous ergonovine testing
ith a negative result, additional intracoronary provocation
ith ACH could reveal coronary spasm in 79%.
In contrast to the Da Costa et al. (9) findings and more
ongruent with our observations, coronary spasm is an
mportant differential diagnosis in Asian patients with ACS
nd unobstructed coronary arteries. Miwa et al. (17) studied
he role of coronary spasm in Japanese patients with stable
nd unstable angina. Intracoronary infusion of ACH pro-
oked coronary spasm in 93% of patients with unstable
ngina, which was significantly higher than in patients with
table angina (20%), who had organic stenoses 50% (p 
.01). However, 30% of their unstable patients also had
xed coronary stenoses (50%) (17). Finally, Wang et al.
8) found in a Taiwanese population a high frequency of
oronary spasm, especially in patients with troponin I–
ositive ACS and insignificant coronary artery disease. In
7 of 23 patients (74%), coronary spasm was provoked by
ntracoronary administration of ergonovine (8).
Although we found a higher incidence of coronary spasm
n our population compared with a previous study in
aucasian patients, we could not reproduce the high pro-
ortion of patients with coronary spasm in the Asian
opulations with ACS. Because the higher prevalence of
oronary vasospasm has also been documented in Asian
opulations with stable effort angina (18), this finding leads
o the assumption that racial differences could explain the
igher prevalence of spasm in the Asian populations.
linically it has been observed that Japanese patients have a
ore diffuse coronary hyperreactivity with an increased aasal tonus. This might be a reason why coronary spasm can
e observed in Japanese patients more often than in Cau-
asians, in whom coronary spasm is reported to be of a more
ocalized nature (18).
One could therefore speculate that coronary spasm in our
atients might be a response to some local arterial injury
hat could vanish after healing. Indeed, patients with coro-
ary spasm had a significantly shorter time interval between
nset of symptoms and ACH test than those without
oronary spasm (mean: 47 h, interquartile range: 24 h to
8 h vs. mean: 65 h, interquartile range: 24 h to 96 h,
ann-Whitney U test). However, in the 16 patients in
hom we performed ACH testing in all 3 coronaries,
ultivessel spasm was found in 69%. This indicates that a
ocal mechanism may not be the only cause for the overre-
ction of the coronary vessels. One possible transient injury
s impairment of endothelial function by virus-induced
nflammation, which was recently shown to occur with
arvovirus B19 infection (19).
Because the clinical situation in which the chest pain
eading to emergent presentation of the patient cannot be
xactly reproduced, some uncertainty about the causal rela-
ionship between the observation of coronary spasm during
CH administration and the clinical event remains. We
hink, however, that the combination of angiographically
ocumented spasm combined with signs of ischemia in the
CG plus exact reproduction of the symptoms leading to
dmission (i.e., chest pain, 42 of 50 patients with coronary
pasm in the ACH test) strongly suggests a causal relation-
hip between spasm and the clinical occurrence of ACS.
luctuation of symptoms is well known in patients with
ngina caused by epicardial coronary stenosis. Hence, one
ight expect that the same might be true in coronary
asospasm. Therefore, asymptomatic coronary spasm in 8 of
ur patients may still be related to the acute chest pain, but
causal relationship is less convincing. Nevertheless,
symptomatic coronary vasospasm may be a clinically im-
ortant finding because serious complications may occur in
uch a setting (20).
tudy limitations. We did not evaluate coagulation abnor-
alities that were previously reported in some cases as a
ause of ACS (21). However, our aim was not to provide
ll-encompassing information about possible causes of chest
ain in patients without culprit lesion but to focus on the
ole of coronary spasm reproduced by ACH testing. There-
ore, other possible causes of chest pain such as myocarditis
ere not systematically ruled out, although in a subgroup of
atients this may have been the underlying cause.
onclusions
very fourth patient with ACS had no culprit lesion at
oronary angiography. In these patients epicardial coronary
pasm could be documented in 50%. Coronary spasm is a
requent cause of ACS and should regularly be considered asdifferential diagnosis. Intracoronary provocation with
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eliably and safely detects coronary spasm to guide institu-
ion of appropriate therapy.
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